A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/1997
10/23/1997	WO1997034586A3 Device and method for treating ophthalmic diseases
10/23/1997	WO1997031114A3 Polynucleotides and aminoacid sequences from staphylococcus aureus
10/23/1997	WO1997030158A3 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
10/23/1997	WO1997026853A3 Dna encoding galanin galr2 receptors and uses thereof
10/23/1997	WO1997025068A3 Mesothelin antigen and methods and kits for targeting it
10/23/1997	DE19617837A1 Anticancer vaccine containing human dendritic cells
10/23/1997	DE19615803A1 CELO-Virus CELO virus
10/23/1997	DE19615710A1 Verfahren zur Gewinnung und Anwendung eines biologisch aktiven Eiweisstoffes - Kollagenfragment HF-COLL-18/514cf - in partiell aufgereinigter und synthetischer Form aus Körperflüssigkeiten zur Beeinflussung des Zellwachstums und der Diagnose von Kollagenerkrankungen sowie der Osteoporose Methods for obtaining and application of a biologically active Eiweisstoffes - collagen fragment HF-COLL-18 / 514cf - in partially purified form from body fluids and synthetic for influencing the cell growth and the diagnosis of collagen diseases and osteoporosis
10/23/1997	CA2251904A1 An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof
10/23/1997	CA2251818A1 Mammalian genes involved in viral infection and tumor suppression
10/23/1997	CA2251733A1 Dhea combination therapy
10/23/1997	CA2241051A1 Targeted therapeutic or diagnostic agents and methods of making and using same
10/22/1997	EP0801951A2 Novel uses of Il-4 and/or Il-10, and antibodies against the same
10/22/1997	EP0801679A1 Monoclonal antibodies which promote central nervous system remyelination
10/22/1997	EP0801658A1 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples
10/22/1997	EP0801656A1 Induction of cytotoxic t-lymphocyte responses
10/22/1997	EP0801572A2 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin
10/22/1997	EP0679093B1 Methods of delivering agents to target cells
10/22/1997	EP0576426B1 Ryegrass pollen allergen
10/22/1997	EP0551449B1 Method for producing a subunit vaccine against porcine parvovirus
10/22/1997	CN1162922A Rheumatoid arthritis remedy containing IL-6 antagonist as active ingredient
10/21/1997	US5679880 Oral immunization by transgenic plants
10/21/1997	US5679784 Recombinant dna molecule comprising adenylate cyclase gene of bordetella
10/21/1997	US5679778 For forming conjugates with macromolecules
10/21/1997	US5679774 DNA sequences of the EBV genome, recombinant DNA molecules, processes for preparing EBV-related antigens, diagnostic compositions and pharmaceutical compositions containing said antigens
10/21/1997	US5679769 Synthesis of asparagine-linked glycopeptides on a polymeric solid support
10/21/1997	US5679768 Epitopic regions of pneumococcal surface protein A
10/21/1997	US5679654 Protecting against abscesses formation associated with surgery, trauma or diseases
10/21/1997	US5679647 Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
10/21/1997	US5679641 Peptides of human P53 protein for use in human T cell response inducing compositions, and human P53 protein-specific cytotoxic t-lymphocytes
10/21/1997	US5679547 Method for producing a novel purified Haemophilus influenzae protein
10/21/1997	US5679531 Methods of detecting βA4 peptide species ending at carboxy-terminus residue 42 using monoclonal antibody 369.2B
10/21/1997	US5679530 Immunogenic complex of isolated polypeptides of specific amino acid sequence to a keyhole lampet hemocyanin
10/21/1997	US5679356 Use of GM-CSF as a vaccine adjuvant
10/21/1997	US5679355 Vaccines containing non-ionic surfactant vesicles
10/21/1997	US5679354 Vaccine having an iscom-like structure comprising at least one lipid and one saponin and being free of incorporated antigens
10/21/1997	US5679353 Bovine trichomonas vaccine compositions
10/21/1997	US5679352 Synthetic Haemophilus influenzae conjugate vaccine
10/21/1997	US5679349 Vaccine design and production
10/21/1997	US5679348 Applying a local therapeutic or prophylactic vaccine for the eye comprising one or more recombinant hsv-1 glycoproteins
10/21/1997	US5679347 Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods
10/21/1997	US5679342 Hepatitis C virus infected cell systems
10/16/1997	WO1997038310A1 Method for detecting organ allograft rejection and uses thereof
10/16/1997	WO1997038138A1 Attenuated respiratory syncytial virus
10/16/1997	WO1997038137A1 Hereditary hemochromatosis gene
10/16/1997	WO1997038118A1 Defective viral vaccine particles obtained in vivo or ex vivo
10/16/1997	WO1997038102A1 Multivalent and multispecific antigen-binding protein
10/16/1997	WO1997038100A1 Human cachexia associated protein
10/16/1997	WO1997038094A1 Influenza virus replicated in mammalian cell culture and vaccine production
10/16/1997	WO1997038087A2 Alphaviral vector with reduced inhibition of cellular macromolecular synthesis
10/16/1997	WO1997038012A1 Extracellular/epidermal growth factor hcaba58x
10/16/1997	WO1997038011A1 Non-dendritic backbone peptide carrier
10/16/1997	WO1997038002A1 Extracellular/epidermal growth factor-like protein
10/16/1997	WO1997037686A1 Process for disintegrating nucleic acids and preparing biological products of guaranteed quality
10/16/1997	WO1997037685A1 GUA MUTANTS OF SHIGELLA spp. AND VACCINES CONTAINING THE SAME
10/16/1997	WO1997037681A1 Medicament for optimising mucosal viscosity and stimulating intestinal function
10/16/1997	WO1997037678A1 Drug for the treatment of tumours
10/16/1997	WO1997037676A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins
10/16/1997	WO1997030178A3 Diagnosing trinucleotide repeat diseases and genes involved therein
10/16/1997	WO1997025071A3 Immunoconjugate for the treatment of aids
10/16/1997	WO1997024138A3 Medical use of proteases
10/16/1997	CA2251464A1 Non-dendritic backbone peptide carrier
10/16/1997	CA2251009A1 Medicament for optimising mucosal viscosity and stimulating intestinal function
10/16/1997	CA2250883A1 Attenuated respiratory syncytial virus
10/16/1997	CA2250868A1 Human cachexia associated protein
10/16/1997	CA2250839A1 Drug for the treatment of tumours
10/16/1997	CA2250835A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins
10/16/1997	CA2250716A1 Influenza virus replicated in mammalian cell culture and vaccine production
10/16/1997	CA2250268A1 Extracellular/epidermal growth factor hcaba58x
10/16/1997	CA2249213A1 Extracellular/epidermal growth factor-like protein
10/15/1997	EP0801132A2 Staphylococcal FtsH protein
10/15/1997	EP0800829A1 Antitumor agent potentiator comprising il-6 antagonist
10/15/1997	EP0800579A2 Combination gene delivery vehicles
10/15/1997	EP0800578A2 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen
10/15/1997	EP0800539A1 Novel cyclodextrin-derivatives and methods for the preparation thereof
10/15/1997	EP0800536A2 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders
10/15/1997	EP0800534A2 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
10/15/1997	EP0800533A1 Anti-inflammatory cd14 peptides
10/15/1997	EP0800531A2 Novel receptor tyrosine kinases
10/15/1997	EP0546036B1 Vaccines
10/15/1997	EP0544781B1 New peptides and their use
10/15/1997	EP0460178B1 Cd4 specific recombinant antibody
10/15/1997	EP0294469B1 Vaccines and diagnostic assays for haemophilus influenzae
10/15/1997	CN1162336A Identification of human cytomegalovirus gene region involved in down-regulation of MHC class I heavy chain expression
10/15/1997	CN1162335A Modified human C3 proteins
10/15/1997	CN1162267A Methods and compositions for specific coagulation of vasculature
10/15/1997	CN1161862A 蛙病毒疫苗 Frog virus vaccine
10/14/1997	US5677438 Polynucletide sequence
10/14/1997	US5677429 Vaccine
10/14/1997	US5677427 Chimeric antibody for detection and therapy of infectious and inflammatory lesions
10/14/1997	US5677426 Anti-IL-8 antibody fragments
10/14/1997	US5677184 Genetic engineered chinese hamster ovary cells
10/14/1997	US5677182 Cleavage site blocking antibody to prohormone proteins and uses thereof
10/14/1997	US5677181 Antitumor, antiinflammatory agents
10/14/1997	US5677180 Chimeric antibody with specificity to human B cell surface antigen
10/14/1997	US5677179 Respiratory system disorder
10/14/1997	US5677176 Animal derived cell with antigenic protein introduced therein
10/14/1997	US5677174 Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity
10/14/1997	US5677171 Inhibit growth of sk-br-3 breast tumor cells
10/14/1997	US5677165 Anti-CD40 monoclonal antibodies capable of blocking B-cell activation

1 ... 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 ... 1823